Jereme Sylvain, EVP and Chief Financial Officer
Professional Overview
Jereme Sylvain is an accomplished finance executive with extensive experience in the medical technology industry. As the Executive Vice President and Chief Financial Officer at Dexcom, he oversees the company's financial strategy, operations, and reporting, playing a crucial role in driving the organization's growth and success.
Experience Summary
Current Role
As the EVP and CFO at Dexcom, a leading global medical device company, Jereme is responsible for managing the company's financial functions, including financial planning and analysis, accounting, treasury, and investor relations. He works closely with the executive team to align financial strategies with Dexcom's overall business objectives, ensuring the company's continued financial stability and profitability.
Career Progression
Jereme's career trajectory has been marked by progressive leadership roles in the finance and accounting domains. Prior to his current position, he served as the SVP of Finance and Chief Accounting Officer at Dexcom, where he played a key role in enhancing the company's financial reporting processes and internal controls. Before that, he held various finance and accounting leadership positions at NuVasive and Life Technologies, where he contributed to the organizations' financial success and strategic growth.
Academic Background
Jereme holds a Master's degree in Accounting from the University of Notre Dame - Mendoza College of Business, demonstrating his strong academic foundation in the field of finance and accounting.
Areas of Expertise
Jereme's expertise spans financial planning and analysis, accounting, treasury management, corporate finance, and regulatory compliance. He has a deep understanding of the medical technology industry, which allows him to align Dexcom's financial strategies with the company's operational and strategic goals.
Professional Impact
Throughout his career, Jereme has made significant contributions to the organizations he has served. At Dexcom, he has played a crucial role in driving the company's financial performance, enabling it to continue its growth trajectory and solidify its position as a leader in the continuous glucose monitoring market. His strategic financial oversight and strong leadership have been instrumental in Dexcom's success.
Conclusion
With his extensive experience, proven track record, and financial expertise, Jereme Sylvain is well-positioned to continue driving Dexcom's financial success and supporting the company's mission to improve the lives of people with diabetes.